Key result
Stroke-HF mortality declines overall since 1999, but surges ~5% annually after 2016.
Why the study?
Trends in mortality with stroke as the underlying cause and heart failure as a contributing condition remain less well defined at the national level in the United States.
How did population-level age-adjusted mortality rates for deaths with stroke as the underlying cause and heart failure as a contributing condition change in the United States from 1999 to 2023?
Cross-Sectional (n=170,303)
How did population-level age-adjusted mortality rates for deaths with stroke as the underlying cause and heart failure as a contributing condition change in the United States from 1999 to 2023?
Effect estimate: AAPC: -1.51% (95% CI -1.70 to -1.26)
Absolute Event Rate: 2.74% vs 4.09%
p-value: p=<0.001
Mortality rates for stroke with contributing heart failure experienced a substantial pre-pandemic reversal, increasing steadily from the mid-2010s and indicating a worsening trajectory for this high-risk cardiovascular phenotype.
Rising stroke-HF mortality since 2016 warrants surveillance; leaves open drivers and whether interventions can reverse trends in this phenotype.
BACKGROUND: National mortality studies have examined deaths in which stroke and heart failure (HF) are listed together, but trends specifically in deaths assigned to stroke as the underlying cause with HF recorded as a contributing condition remain less well defined. METHODS: We analyzed CDC WONDER Multiple Cause of Death data for US decedents aged ≥15 years from 1999 to 2023. Stroke was defined by ICD-10 codes I60-I69 as the underlying cause of death, and HF by code I50 as a contributing condition. Age-adjusted mortality rates (AAMRs) per 100,000 population were assessed using Joinpoint regression. Analyses included sex, race, Hispanic origin, urbanization, and state. A sensitivity analysis restricted to 1999-2019, supplemented by AR(1) robustness analyses, evaluated whether the late-period reversal preceded COVID-19. RESULTS: Among 170,303 qualifying deaths, AAMR declined from 4.09 in 1999 to 2.74 in 2023 (AAPC: -1.51%; p < 0.001). Mortality declined through 2009, remained stable during 2009-2016, and increased during 2016-2023 (APC: +5.38%). The pre-pandemic sensitivity analysis confirmed a significant increase during 2014-2019 (APC: +3.04%; 95% CI: +2.06% to +4.77%; p < 0.001), which remained significant in AR(1) robustness analyses, including with positive autocorrelation fixed at ρ = 0.30 (APC: +3.02%; 95% CI: +1.01% to +8.02%; p = 0.020). The male-to-female AAMR ratio increased significantly during 2009-2023, despite nonsignificant terminal APCs within the male series. Among racial groups retained in the primary analysis, Black individuals had the highest AAMRs. AAMRs were higher in less urbanized areas, and state-level AAMRs ranged from 1.05 in Arizona to 5.36 in Mississippi. CONCLUSIONS: Mortality with stroke as the underlying cause and HF as a contributing condition declined substantially before reversing in the mid-2010s. Rates increased more sharply during the pandemic-era years, superimposed on an increase that was already evident before 2020. Persistent racial, geographic, and urbanization disparities warrant continued surveillance and targeted prevention.
No takes yet. Share an insight, caveat, or question.
Bsharat et al. (2026) conducted a cross-sectional in Stroke with heart failure as a contributing condition (n=170,303). Observation period (1999-2023) vs. Prior time periods (e.g., 1999 vs 2023) was evaluated on Age-adjusted mortality rate (AAMR) per 100,000 population (AAPC: -1.51%, 95% CI -1.70 to -1.26, p=<0.001). Age-adjusted mortality for stroke with contributing heart failure declined overall from 1999 to 2023 (AAPC -1.51%), but reversed course with a significant 5.38% annual increase from 2016 to 2023.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: